title: Evidence for physiologically active axonal adenosine receptors in the rat corpus callosum.
abstract: Several neurotransmitter receptors have been identified on axons, and emerging evidence suggests that central axonal conduction may be modulated by neurotransmitters. We have recently demonstrated the presence of extra-synaptic adenosine Al receptors along rat hippocampal axons. We now present immunocytochemical evidence for Al receptors on rat corpus callosum axons and show that these receptors actively modulate axon physiology. Using rat brain coronal slices, we stimulated the corpus callosum and recorded the evoked extracellular compound action potential. The lipid-soluble, Al-specific adenosine receptor agonist cyclopentyladenosine, dose-dependently decreased the compound action potential amplitude, an effect reversed by the specific Al antagonist 8-cyclopentyl-1, 3-dipropylxanthine. These data provide the first direct evidence that axonal Al adenosine receptors modulate axon physiology in the adult mammalian brain. Influencing axonal transmission is a potentially powerful mechanism of altering information processing in the nervous system.
authors.affiliation: Departments of Anatomy, Neurobiology and Medicine, The Medical College of Ohio, Toledo, OH, USA.
authors.forename: T H
authors.initials: TH
authors.lastname: Swanson
authors.forename: S E
authors.initials: SE
authors.lastname: Krahl
authors.forename: Y Z
authors.initials: YZ
authors.lastname: Liu
authors.forename: J A
authors.initials: JA
authors.lastname: Drazba
authors.forename: S A
authors.initials: SA
authors.lastname: Rivkees
mesh_terms: D000200:Action Potentials / Q000187:drug effects; D000241:Adenosine / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D001369:Axons / Q000187:drug effects / Q000502:physiology*; D002110:Caffeine / Q000494:pharmacology; D003337:Corpus Callosum / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D004594:Electrophysiology; D007150:Immunohistochemistry; D008297:Male; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology; D058906:Purinergic P1 Receptor Agonists; D058915:Purinergic P1 Receptor Antagonists; D051381:Rats; D017207:Rats, Sprague-Dawley; D018047:Receptors, Purinergic P1 / Q000378:metabolism*; D013569:Synapses / Q000187:drug effects; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology
chemical_list: D010726:Phosphodiesterase Inhibitors; D058906:Purinergic P1 Receptor Agonists; D058915:Purinergic P1 Receptor Antagonists; D018047:Receptors, Purinergic P1; D002110:Caffeine; C048599:N(6)-cyclopentyladenosine; D000241:Adenosine